Found: 80
Select item for more details and to access through your institution.
Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis.
- Published in:
- GeroScience, 2024, v. 46, n. 1, p. 463, doi. 10.1007/s11357-023-00846-x
- By:
- Publication type:
- Article
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis.
- Published in:
- Annals of Neurology, 1996, v. 40, n. 6, p. 846, doi. 10.1002/ana.410400606
- By:
- Publication type:
- Article
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis.
- Published in:
- Journal of Neuroinflammation, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12974-015-0257-0
- By:
- Publication type:
- Article
Serum neurofilament light levels in normal aging and their association with morphologic brain changes.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14612-6
- By:
- Publication type:
- Article
Levels of Matrix Metalloproteinase-9 within Cerebrospinal Fluid in a Rabbit Model of Coccidioidal Meningitis and Vasculitis.
- Published in:
- Journal of Infectious Diseases, 2002, v. 186, n. 11, p. 1692, doi. 10.1086/345365
- By:
- Publication type:
- Article
Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis.
- Published in:
- Journal of Infectious Diseases, 2000, v. 182, n. 1, p. 347, doi. 10.1086/315658
- By:
- Publication type:
- Article
Gene expression in cortex and hippocampus during acute pneumococcal meningitis.
- Published in:
- BMC Biology, 2006, v. 4, p. 15, doi. 10.1186/1741-7007-4-15
- By:
- Publication type:
- Article
Development of an age‐adjusted model for blood neurofilament light chain.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 4, p. 444, doi. 10.1002/acn3.51524
- By:
- Publication type:
- Article
Ratio and index of Neurofilament light chain indicate its origin in Guillain‐Barré Syndrome.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 11, p. 2213, doi. 10.1002/acn3.51207
- By:
- Publication type:
- Article
Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 6, p. 945, doi. 10.1002/acn3.51060
- By:
- Publication type:
- Article
Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 9, p. 1757, doi. 10.1002/acn3.50872
- By:
- Publication type:
- Article
Blood neurofilament light as a potential endpoint in Phase 2 studies in MS.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 6, p. 1081, doi. 10.1002/acn3.795
- By:
- Publication type:
- Article
Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1478, doi. 10.1002/acn3.638
- By:
- Publication type:
- Article
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
- Published in:
- Annals of Clinical & Translational Neurology, 2014, v. 1, n. 9, p. 659, doi. 10.1002/acn3.94
- By:
- Publication type:
- Article
Demographic and disease‐related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis.
- Published in:
- Brain & Behavior, 2023, v. 13, n. 1, p. 1, doi. 10.1002/brb3.2873
- By:
- Publication type:
- Article
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2081, doi. 10.1177/13524585221109761
- By:
- Publication type:
- Article
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 4, p. 573, doi. 10.1177/13524585211032348
- By:
- Publication type:
- Article
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 3, p. 429, doi. 10.1177/13524585211024997
- By:
- Publication type:
- Article
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2219, doi. 10.1177/13524585211000280
- By:
- Publication type:
- Article
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2001, doi. 10.1177/13524585211047977
- By:
- Publication type:
- Article
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1670, doi. 10.1177/1352458519881428
- By:
- Publication type:
- Article
Serum NfL levels should be used to monitor multiple sclerosis evolution – Yes.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 17, doi. 10.1177/1352458519872921
- By:
- Publication type:
- Article
Fluid biomarker and electrophysiological outcome measures for progressive MS trials.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 14, p. 1600, doi. 10.1177/1352458517732844
- By:
- Publication type:
- Article
Fluid biomarker and electrophysiological outcome measures for progressive MS trials.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 12, p. 1600, doi. 10.1177/1352458517732844
- By:
- Publication type:
- Article
A comparative study of CSF neurofilament light and heavy chain protein in MS.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 12, p. 1597, doi. 10.1177/1352458513482374
- By:
- Publication type:
- Article
A Method to Combine Neurofilament Light Measurements From Blood Serum and Plasma in Clinical and Population-Based Studies.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.894119
- By:
- Publication type:
- Article
Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation.
- Published in:
- Journal of NeuroImmune Pharmacology, 2019, v. 14, n. 4, p. 709, doi. 10.1007/s11481-019-09872-z
- By:
- Publication type:
- Article
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Reply to: Neurofilament Light Chain in Patients with COVID-19 and Bacterial Pneumonia.
- Published in:
- 2021
- By:
- Publication type:
- letter
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019.
- Published in:
- Annals of Neurology, 2021, v. 89, n. 3, p. 610, doi. 10.1002/ana.26004
- By:
- Publication type:
- Article
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis.
- Published in:
- Annals of Neurology, 2014, v. 76, n. 2, p. 231, doi. 10.1002/ana.24190
- By:
- Publication type:
- Article
On being a neurologist in industry.
- Published in:
- Annals of Neurology, 2013, v. 73, n. 3, p. 319, doi. 10.1002/ana.23812
- By:
- Publication type:
- Article
Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathies.
- Published in:
- Acta Neuropathologica, 2003, v. 105, n. 1, p. 37, doi. 10.1007/s00401-002-0607-8
- By:
- Publication type:
- Article
MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.
- Published in:
- Cellular & Molecular Life Sciences, 2019, v. 76, n. 16, p. 3097, doi. 10.1007/s00018-019-03174-6
- By:
- Publication type:
- Article
Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 11, p. 2710
- By:
- Publication type:
- Article
Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.
- Published in:
- Journal of Neurology, 2007, v. 254, n. 2, p. 160, doi. 10.1007/s00415-006-0299-4
- By:
- Publication type:
- Article
C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 7, p. 1081, doi. 10.1007/s00259-015-3043-4
- By:
- Publication type:
- Article
Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20398-y
- By:
- Publication type:
- Article
The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17282-0
- By:
- Publication type:
- Article
Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.814064
- By:
- Publication type:
- Article
Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1095038
- By:
- Publication type:
- Article
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 5, p. 1389, doi. 10.1111/ene.15742
- By:
- Publication type:
- Article
Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, p. 1, doi. 10.1177/17562864221080528
- By:
- Publication type:
- Article
Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, v. 15, p. 1, doi. 10.1177/17562864221080528
- By:
- Publication type:
- Article
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, p. 1, doi. 10.1177/20552173211069348
- By:
- Publication type:
- Article
White matter lesion location correlates with disability in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, v. 6, n. 1, p. 1, doi. 10.1177/2055217320906844
- By:
- Publication type:
- Article
MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis.
- Published in:
- Journal of Neuroimaging, 2021, v. 31, n. 2, p. 388, doi. 10.1111/jon.12826
- By:
- Publication type:
- Article